Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer
about
Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.Coming of Age: CD96 Emerges as Modulator of Immune Responses.Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment.Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals
P2860
Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Altered expression of CD226 an ...... atients with pancreatic cancer
@en
Altered expression of CD226 an ...... tients with pancreatic cancer.
@nl
type
label
Altered expression of CD226 an ...... atients with pancreatic cancer
@en
Altered expression of CD226 an ...... tients with pancreatic cancer.
@nl
prefLabel
Altered expression of CD226 an ...... atients with pancreatic cancer
@en
Altered expression of CD226 an ...... tients with pancreatic cancer.
@nl
P2093
P2860
P356
P1433
P1476
Altered expression of CD226 an ...... atients with pancreatic cancer
@en
P2093
Chun-Hua Xi
Ji-Shu Wei
Jing-Jing Zhang
Ling-Di Yin
Xin-Chun Liu
Yun-Peng Peng
P2860
P304
66586-66594
P356
10.18632/ONCOTARGET.11953
P407
P577
2016-09-10T00:00:00Z